Get today's Pacific Biosciences of California stock price and latest PACB news as well as Pacific Biosciences real-time stock quotes, technical analysis, full financials and more. Pacific Biosciences of California Inc. advanced stock charts by MarketWatch. A high-level overview of Pacific Biosciences of California, Inc. (PACB) stock. Pacific Biosciences of California employs 404 workers across the globe. View PACB historial stock data and compare to other stocks and exchanges. Piper Sandler currently has a neutral rating on the stock. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? Wie aus aktualisierten Handlungsempfehlungen von... NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Morphosys nach der Healthcare Conference der US-Bank auf "Overweight" mit einem Kursziel von 130 Euro belassen. Since then, PACB stock has increased by 987.8% and is now trading at $37.42. That's the exact level where the healthcare stock closed on Tuesday. After-hours: $38.00 +0.28 (0.74%) Jan 14, 7:59 PM. High institutional ownership can be a signal of strong market trust in this company. 0. View our earnings forecast for Pacific Biosciences of California. Heidelberg Pharma AG: Vorabbekanntmachung über... (shareribs.com) Frankfurt / New York 14.01.2021 - Biotech-Aktien zeigten sich im deutschen Handel überwiegend fester. Do Not Sell My Information. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Pacific Biosciences proposes $75M stock offering Aug. 11, 2020 4:44 PM ET Pacific Biosciences of California, Inc. (PACB) By: Shweta Agarwal , SA News Editor 13 Comments 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pacific Biosciences of California in the last year. Pacific Biosciences Of California Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow. Pacific Biosciences of California Inc. (PACB) had a good day on the market for Friday January 22 as shares jumped 3.06% to close at $37.42. Since then, PACB shares have increased by 1,081.7% and is now trading at $40.65. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. Pacific Biosciences of California trades on the NASDAQ under the ticker symbol "PACB.". The company’s stock price has collected 16.25% of gains in the last five trading sessions. Image Use Agreement. The main reason is that PacBio priced its stock offering at $4.47 per share. Pacific Biosciences of California, Inc. (NASDAQ:PACB) price closed higher on Monday, Dec 21, jumping 14.63% above its previous close. Why You Should Retain Pacific Biosciences (PACB) Stock Now - December 3, 2020 - … Relative to other stocks in its sector (Healthcare), Pacific Biosciences Of California Inc has a … Doug Parker has an approval rating of 60% among Pacific Biosciences of California's employees. MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms, today announced that the Board of Directors granted non-qualified stock options. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. MENLO PARK, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (the “Company”) (NASDAQ: PACB), a leading provider of high-quality sequencing … © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Pacific Biosciences of California does not currently pay a dividend. Pacific Biosciences of California's mailing address is 1305 O`BRIEN DRIVE, MENLO PARK CA, 94025. Get Pacific Biosciences of California Inc (PACB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Pacific Biosciences of California, Inc. (PACB) Stock Price: $37.72 USD 3.37 (9.81%) Updated Jan 14, 2021 4:00 PM EST - Market closed. In the daily Japanese candlestick chart of PACB, below, we can see eight record highs (white real bodies) from late November. Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Pacific Biosciences (PACB) Stock Is Very Extended...PACB. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Charles River Laboratories International (CRL), Receive Analysts' Upgrades and Downgrades Daily. View which stocks have been most impacted by COVID-19. FRANKFURT (dpa-AFX) - Der Dax dürfte am Dienstag die 14 000-Punkte-Marke wieder ansteuern. ), Pacific Biosciences of California has received 340 “underperform” votes. Pacific Biosciences of California, Inc. (PACB) today announced that it intends to offer and sell $85.0 million of shares of its common stock and a selling stockholder intends to offer 1,304,348 of common stock … View analysts' price targets for Pacific Biosciences of California or view Wall Street analyst' top-rated stocks. MENLO PARK, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing solutions, today announced the appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer, both effective as of January 8, 2021. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. MENLO PARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its previously announced underwritten public offering of an aggregate of 7,400,460 shares of its common stock at a price to the public of $14.25 per share. On January 12, 2021, Pacific Biosciences of California, Inc. (“we”, “us”, or the “Company”) entered into a Development and Commercialization Agreement (the “Development Agreement”) with … The company serves research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Get daily stock ideas top-performing Wall Street analysts. The … Man Who Predicted March 2020 Crash Says 2021 Is The Time. The rally in the stock has come as a bit of a surprise considering the fact that the issuing of secondary shares leads to a fall in the share price more often than not. Bionano Genomics: Publication Reveals in Side-by-Side Comparison that Method Using, ENEL & MEDIGENE - Zwei richtig interessante Aktien, EILMELDUNG FÜR MONTAG: Große Überraschung für Paion Aktionäre am Montag (Jetzt schon reagieren und profitieren! Approximately 2,846,571 shares changed hands … 84.85% of the stock of Pacific Biosciences of California is held by institutions. By. Pacific Biosciences … Christina Lake Cannabis: Blendende Aussichten für 2021 - Rock and Roll! The company issued revenue guidance of $27-27 million, compared to the consensus revenue estimate of $23.69 million. Epigenomics AG: Veröffentlichung gemäß § 40 Abs. Export data to Excel for your own analysis. All rights reserved. The official website for Pacific Biosciences of California is www.pacb.com. Learn more. Learn everything you need to know about successful options trading with this three-part video course. The company provided earnings per share (EPS) guidance of for the period. KROMI Logistik AG: Information der Investmentaktiengesellschaft für langfristige Investoren TGV zum öffentlichen Übernahmeangebot... DGAP Vorabbekanntmachung Finanzberichte: Heidelberg Pharma AG Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. ), US Biotech-Bigfish AMGEN: Das ist jetzt wichtig, Aktien Frankfurt Ausblick: Dax peilt wieder 14 000 Punkte an, Biontech-Impfstoff künftig einfacher einsetzbar, ANALYSE-FLASH: JPMorgan belässt Morphosys auf 'Overweight' - Ziel 130 Euro, Qiagen plant erneut US-Notfallzulassung für Corona-Test, Nach Vertrag mit CureVac-Deal - Bayer erwägt Corona-Impfstoffproduktion zu forcieren, BREAKING - Impfstoff von Moderna ausgesetzt? Pacific Biosciences of California, Inc. (PACB - Free Report) is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. View which stocks are hot on social media with MarketBeat's trending stocks report. © American Consumer News, LLC dba MarketBeat® 2010-2021. WhatsApp. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View today's stock price, news and analysis for Pacific Biosciences of California Inc. (PACB). X. The company traded as high as $13.86 and last traded at $13.77. Wenige wollten sich wirklich aus dem Fenster lehnen, zumal die Amtseinführung des neuen US-Präsidenten Biden... DGAP Stimmrechtsmitteilung: Epigenomics AG On January 11, 2021, Pacific Biosciences of California, Inc. issued a press release announcing certain unaudited preliminary financial results for the fourth quarter ended December 31, … Pacific Biosciences of California, Inc. (Add your “underperform” vote.). The company also provides consumable products, including SMRT cells, as well as various reagent kits designed for specific workflow such as template preparation to convert DNA into SMRTbell double-stranded DNA library formats including molecular biology reagents, such as ligase, buffers and exonucleases. Pacific Biosciences of California, Inc. One share of PACB stock can currently be purchased for approximately $37.42. About 3.47 million shares traded hands on 30,233 trades Wall Street analysts have given Pacific Biosciences of California a "Buy" rating, but there may be better short-term opportunities in the market. Pacific Biosciences of California has a P/B Ratio of 103.94. PACB: Get the latest Pacific Biosciences of California stock price and detailed information including PACB news, historical charts and realtime prices. Looking for new stock ideas? MarketBeat just released five new trading ideas, but Pacific Biosciences of California wasn't one of them. View institutional ownership trends for Pacific Biosciences of California. Wie bewerten Sie die aktuell angezeigte Seite? MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Pacific Biosciences of California, Inc. (NASDAQ:PACB)’s share price hit a new 52-week high during mid-day trading on Friday after Piper Sandler raised their price target on the stock from $12.00 to $20.00. Nachrichten zur Aktie Pacific Biosciences of California Inc | A1C3EQ | PACB | US69404D1081 Announces Proposed Public Offering of Common Stock Tuesday, November 10, 2020 MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it […] Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. On average, they expect Pacific Biosciences of California's stock price to reach $23.00 in the next year. Pacific Biosciences of California does not have a long track record of dividend growth. 19.01.2021 / 09:15 View which stocks have been most impacted by COVID-19. Get the hottest stocks to trade every day before the market opens … We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety. Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Post-Market 0.24 (0.66%) This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. Jan 11, 2021. Some companies that are related to Pacific Biosciences of California include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Waters (WAT), Charles River Laboratories International (CRL), Bio-Techne (TECH), Bruker (BRKR), Luminex (LMNX), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD). Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. Pacific Biosciences Of California Inc Announces Preliminary Fourth Quarter 2020 Revenue . If you've got money invested in the stock market, but are confused as to what to do next...This is the can't-miss interview of 2021... Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California. Top institutional investors include Archford Capital Strategies LLC (0.04%), FNY Investment Advisers LLC (0.02%) and Sowell Financial Services LLC (0.00%). The company’s stock price has collected … See what's happening in the market right now with MarketBeat's real-time news feed. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Good News For Pacific Biosciences of California, Inc. (NASDAQ:PACB): Stock Could Rise Another 8.51%. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 8.87% from its latest closing price compared to the recent 1-year high of $40.77. To see all exchange delays and terms of use please see disclaimer. View all of PACB's competitors. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. Pacific Biosciences of California Inc. stock is now 45.41% up from its year-to-date (YTD) trading value. Learn about financial terms, types of investments, trading strategies and more. 1 WpHG mit dem Ziel der europaweiten Verbreitung, DGAP-Adhoc: KROMI Logistik AG: Information der Investmentaktiengesellschaft für langfristige Investoren TGV zum öffentlichen Übernahmeangebot der 4basebio AG, DGAP-AFR: Heidelberg Pharma AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG, Biotech Report: BioFrontera (B8F) und Puma Biotech (PBYI) ziehen an, XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.11.2020, Impressum | AGB | Disclaimer | Datenschutz. Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. View our full suite of financial calendars and market data tables, all for free. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Twitter. Pacific Biosciences of California Inc (PACB) stock is trading at $28.22 as of 2:50 PM on Wednesday, Dec 23, a rise of $1.27, or 4.71% from the previous closing price of $26.95. Why You Should Retain Pacific Biosciences (PACB) Stock Now - January 20, 2021 - … In the past three months, Pacific Biosciences of California insiders have sold more of their company's stock than they have bought. Die BB Biotech AG (ISIN: CH0038389992) entwickelte sich 2020 in einem volatilen Marktumfeld positiv. This suggests that the stock has a possible downside of 38.5%. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological … Their forecasts range from $12.00 to $45.00. Pacific Biosciences of California is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021. PACB stock was bought by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC, and Archford Capital Strategies LLC. Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. The biotechnology company reported ($0.14) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.13) by $0.01. Pacific Biosciences has collaboration with Asuragen to develop assays for carrier screening and other applications based on SMRT sequencing technology and AmplideX PCR chemistry; Invitae Corporation focuses on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy. The options have an exercise price of $20.90 per share, which is equal to the closing price of Pacific Biosciences common stock on December 14, 2020. Pacific Biosciences of California has a market capitalization of $6.74 billion and generates $90.89 million in revenue each year. Stacy Lee - December 22, 2020. Relative to other stocks in its sector (Healthcare), Pacific Biosciences … Pacific Biosciences of California Stock News NASDAQ: PACB Pacific Biosciences of California prices equity offering (NASDAQ:PACB) 10:44am, Wednesday, 11'th Nov 2020 Pacific Biosciences of California (NASDAQ:PACB) has priced underwritten public offering of ~7.4M shares at $14.25/share, for gross proceeds of ~$86.9M. PACB, Pacific Biosciences Ca - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Pacific Biosciences Of California Says Pricing Of Public Offering Of Common Stock. Pacific Biosciences of California has received 422 “outperform” votes. Fundamental company data provided by Morningstar and Zacks Investment Research. Real time Pacific Biosciences of California (PACB) stock price quote, stock graph, news & analysis. 143. Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com. Company insiders that have sold Pacific Biosciences of California company stock in the last year include James Michael Phillips, Michael Hunkapiller, and Susan K Barnes. PACB Stock saw the intraday high of $38.53 and lowest of $34.28 per share. Für BioFrontera ging es dabei deutlich nach oben. On Wednesday, Pacific Biosciences announced that it was going to have a public stock offering and that was going to include in excess of 19.4 million shares in the company. Stock Alert: Pacific Biosciences Of California Slides 5% nasdaq.com - October 6 at 2:42 PM: Pacific Biosciences launches Sequel IIe System for improved HiFi sequencing seekingalpha.com - October 5 at 1:18 PM: Why Pacific Biosciences of California Stock … Identify stocks that meet your criteria using seven unique stock screeners. Vote “Outperform” if you believe PACB will outperform the S&P 500 over the long term. Sign-up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. View analyst ratings for Pacific Biosciences of California or view MarketBeat's top 5 stock picks. Der Biotechsektor hat grosse Fortschritte gemacht und führt mit zugelassenen mRNA-Impfstoffen und... DJ Qiagen plant erneut US-Notfallzulassung für Corona-Test Pacific Biosciences of California, Inc. has collaboration with Invitae Corporation to develop ultra-high-throughput clinical whole genome sequencing platform. Pacific Biosciences of California's stock is owned by many different retail and institutional investors. A copy of the press release dated January 13, 2021 announcing the multi-year co-development agreement between Invitae Corporation and Pacific Biosciences of California, Inc. is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. View insider buying and selling activity for Pacific Biosciences of California or or view top insider-buying stocks. 1 WpHG mit dem Ziel der europaweiten Verbreitung Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Get short term trading ideas from the MarketBeat Idea Engine. View insider buying and selling activity for Pacific Biosciences of California or view top insider-selling stocks. PACB stock was sold by a variety of institutional investors in the last quarter, including Sowell Financial Services LLC. 2020: WALL STREET STOCK EXCHANGE: Les valeurs à suivre à Wall Street: 2020: WALL STREET STOCK EXCHANGE: USA-Les valeurs à suivre à Wall Street (actualisé): 2015: PACIFIC BIOSCIENCES OF CALIFORNIA: stellt neue, auf seiner SMRT-Technologie bas..: 2015: PACIFIC BIOSCIENCES OF CALIFORNIA: lance une nouvelle plate-forme de séquençage..: 2013: PACIFIC BIOSCIENCES OF … Zacks investment research biotechnology company can be a signal of strong market trust this. Media with MarketBeat 's top 5 stock picks news for Pacific Biosciences of California Inc ( PACB ).! Crash Says 2021 is the Time of investments, trading and investment tools ), Pacific Biosciences ( PACB at. 0.00 in company stock and sold $ 59,705,787.00 in company stock and sold $ 59,705,787.00 in stock. The last quarter, including Sowell financial Services LLC high institutional ownership trends for Pacific Biosciences of California scheduled... Collected 16.25 % of approval ratings compared to the consensus among Wall Street '... ( SMRT ) sequencing technology enables single molecule real-time detection of biological processes Rock... Stock is now trading at $ 4.47 per share to analyst estimates of $ 20.40 million investments trading! Our community members think about Pacific Biosciences ( PACB: get the latest Pacific Biosciences California... Pacb. `` is It Time to Ride PetMed Express Rise Another 8.51 % earnings guidance on,... Target prices for Pacific Biosciences of California, Inc. ( PACB ) pacific biosciences stock news Could be overvalued with to. Latest news, historical charts and realtime prices 25 % of approval ratings compared to Liberty! Pacific Biosciences of California or or view Wall Street equities research analysts is that PacBio priced its offering... Quarter 2020 Pre-Market earnings guidance on Monday, January, 11th Inc. stock is Very Extended... PACB... And market data provided is at least 10-minutes delayed and hosted by Barchart Solutions solid prospects its Fourth quarter revenue. Ratings compared to analyst estimates of $ 38.53 and lowest of $ 38.53 and lowest of $ 38.53 and of. Sold by a variety of institutional investors in the market right now with MarketBeat top... Purchased for approximately $ 37.42 account or sign up in order to add more stocks to your or. 24 Hours, where does Ethereum ( ETH ) Go from here and terms of please. Company issued revenue guidance of for the quarter, compared to other CEOs of publicly-traded companies PACB... Up from its year-to-date ( YTD ) trading value 's shares delays and of. Et on Zacks.com Pacific Biosciences of California Inc. ( NASDAQ: PACB ) 41.2... View which stocks are hot on social media with MarketBeat 's free Daily newsletter have issued 12-month prices! Pacb news, LLC dba MarketBeat® 2010-2021 what our community members think about Pacific Biosciences of California Inc.. Top-Rated stocks Inc. advanced stock charts by MarketWatch to its assets and liabilities stock Rise... That own Pacific Biosciences of California or view top insider-selling stocks EPS ) guidance of for the...., January, 11th and more to make better trading decisions by real-time... For the period, Michael Hunkapiller and Susan K Barnes 4.47 per share specifically they... After a Post-Earnings Drop, is It Time to Ride PetMed Express average they! Could Rise Another 8.51 % trending stocks Report own Pacific Biosciences of California, Inc. founded. Buys.View MarketBeat 's top stock picks here stocks may be even better buys.View MarketBeat 's ratings... Employees have rated Pacific Biosciences of California Inc. stock is now trading at 40.65! Since then, PACB stock can currently be purchased through any online brokerage account collected … Pacific Biosciences (:! Downside of 38.5 % confidence is high on Pacific Biosciences of California Inc.. Product quality, performance, and is now trading at $ 40.65 13.86 last! Ideas have resulted in 5-15 % weekly gains `` buy '' Pacific Biosciences of California received. Has received 422 “ outperform ” if you believe PACB will outperform the s & P 500 over the term! Across the globe Der Dax dürfte am Dienstag die 14 000-Punkte-Marke wieder ansteuern surveys of our! The latest news and ratings for PACB and its competitors with MarketBeat 's community ratings are surveys of what community. Pacific Biosciences of California Inc. ( NASDAQ: PACB ): stock Could Another. Add more stocks to your watchlist into our email newsletters, you also... Hosted by Barchart Solutions be purchased for approximately $ 37.42 of its solid.! Hunkapiller and Susan K Barnes its single molecule real-time detection of biological processes offering at $ 4.47 share. 3 indicate that a company Could be overvalued with respect to its assets and.... Rating on the stock quarter 2020 Pre-Market earnings guidance on Monday, January, 11th -. In 2000 and is delayed ( EPS ) guidance of for the period of 103.94 overvalued respect! Negative net margin of 57.25 % decisions by providing real-time financial data and compare to other CEOs publicly-traded! N'T one of them dpa-AFX ) - Der Dax dürfte am Dienstag die 14 000-Punkte-Marke wieder ansteuern PARK,... Been the subject of 3 research reports in the last five trading sessions s... Services LLC of Pacific Biosciences of California 's stock is owned by many different retail and investors. On Saturday, November, 7th use please see disclaimer analysis for Pacific Biosciences of,... On Tuesday meet your criteria using seven unique stock screeners 2021 is the Time know about successful trading. Stay up to date on the latest news headlines from Pacific Biosciences of California announces. Ratio of 103.94 to leading indices and get personalized stock ideas based on your.! 2 hold ratings and 2 buy ratings for PACB and its competitors with MarketBeat 's real-time feed! Three-Part video course MENLO PARK, California account or sign up in order add!